Blog
Supreme Court Grants Cert. Petition in Hikma / Amarin Skinny Labeling Case
Key Takeaways: Supreme Court to decide if “generic version” marketing can support induced infringement claims. On Jan. 16, 2026, the Court granted Hikma’s petition for cert. in a closely watched case that could redefine the limits of skinny labeling and induced infringement law for generic drugs and biosimilars….
By: Polsinelli